======= NRDE2 ======= == Gene Information == * **Official Symbol**: NRDE2 * **Official Name**: NRDE-2, necessary for RNA interference, domain containing * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=55051|55051]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9H7Z3|Q9H7Z3]] * **Interactions**: [[https://thebiogrid.org/search.php?search=NRDE2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NRDE2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/618631|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A |DUF1740| |chromatin silencing by small RNA| |RNA interference| |posttranscriptional gene silencing by RNA| |posttranscriptional gene silencing| |chromatin organization involved in negative regulation of transcription| |chromatin silencing| |chromatin organization involved in regulation of transcription| |negative regulation of gene expression, epigenetic| |gene silencing by RNA| |gene silencing| |regulation of gene expression, epigenetic| |cellular component| |posttranscriptional regulation of gene expression| |chromatin organization| |molecular function| |chromosome organization| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |negative regulation of gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp52|Ribavirin 10μM R01 exp52]]|-2.52| |[[:results:exp61|YM155 0.0002μM R01 exp61]]|-2.35| |[[:results:exp49|NFN1 0.1μM R01 exp49]]|-2.16| |[[:results:exp521|Salinomycin 3.5μM R08 exp521]]|-2.04| |[[:results:exp58|UM131593 0.1μM R01 exp58]]|-1.94| |[[:results:exp60|Vinblastine 0.002μM R01 exp60]]|-1.92| |[[:results:exp59|UMK57 1μM R01 exp59]]|-1.91| |[[:results:exp507|Monensin 0.3μM R08 exp507]]|-1.85| |[[:results:exp50|Nicotinamide 2000μM R01 exp50]]|-1.81| |[[:results:exp288|HMS-I2 10μM R06 exp288]]|-1.79| |[[:results:exp135|MS023 7μM R03 exp135]]|-1.79| |[[:results:exp130|JQ1 0.01μM R03 exp130]]|1.75| |[[:results:exp528|TGF-beta1 44ng/ml R08 exp528]]|1.75| |[[:results:exp80|RO-3307 4.7μM R02 exp80]]|1.78| |[[:results:exp534|Trientine 500μM R08 exp534]]|1.81| |[[:results:exp77|Prochlorperazine 5.2μM R02 exp77]]|1.91| |[[:results:exp249|Vinorelbine 0.001μM R05 exp249]]|1.94| |[[:results:exp129|Isonicotinamide 500μM R03 exp129]]|2.02| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 568/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|1/1| |bile duct|22/28| |blood|20/28| |bone|22/26| |breast|23/33| |central nervous system|46/56| |cervix|2/4| |colorectal|13/17| |esophagus|7/13| |fibroblast|1/1| |gastric|11/16| |kidney|20/21| |liver|15/20| |lung|52/75| |lymphocyte|12/16| |ovary|20/26| |pancreas|16/24| |peripheral nervous system|16/16| |plasma cell|14/15| |prostate|0/1| |skin|19/24| |soft tissue|9/9| |thyroid|1/2| |upper aerodigestive|14/22| |urinary tract|18/29| |uterus|5/5| == Essentiality in NALM6 == * **Essentiality Rank**: 635 * **Expression level (log2 read counts)**: 6.26 {{:chemogenomics:nalm6 dist.png?nolink |}}